loading

Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
19.24%
5.785
7.163 - - -
Operating Expenses
16.23%
16.51
19.71 15.05 17.49 19.56
Benefits Costs and Expenses
14.86
- - - -
Costs And Expenses
14.86
- - - -
Operating Income/Loss
14.52%
-10.73
-12.55 -15.05 -17.49 -19.56
Nonoperating Income/Loss
1.85%
1.652
1.622 0.628 0.592 0.609
Income/Loss From Continuing Operations Before Tax
16.95%
-9.077
-10.93 -14.42 -16.90 -18.95
Income/Loss From Continuing Operations After Tax
17.20%
-9.077
-10.96 -14.42 -16.90 -18.95
Net Income/Loss
17.20%
-9.077
-10.96 -14.42 -16.90 -18.95
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
111.57%
5.4833
-47.37 52.57 52.26 51.01
Diluted Average Shares
111.57%
5.4833
-47.37 52.57 52.26 51.01
Basic Earnings Per Share
86.62%
-1.66
-12.41 -0.27 -0.32 -0.37
Diluted Earnings Per Share
86.62%
-1.66
-12.41 -0.27 -0.32 -0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):